Viewing Study NCT01541332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-06-16 @ 8:31 AM
Study NCT ID: NCT01541332
Status: UNKNOWN
Last Update Posted: 2016-03-10
First Post: 2012-02-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma
Sponsor: Oncotherapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed refractory View
None multiple myeloma View
None pomalidomide View
None Doxil View
None dexamethasone View
None Oncotherapeutics View